Yasodha Natkunam

Dr. Natkunam is an expert in the diagnosis of hematopoietic tumors including lymphoma and leukemia and has 20-years of experience in the hematopathology diagnostic services of Stanford Health and Stanford Children’s Health. Her research focuses on refining the diagnosis and prognosis of patients with hematopoietic tumors and has furnished novel reagents, diagnostic criteria and guidelines for clinical practice. She currently serves on a number of editorial boards, expert panels and professional societies in her field.

Clinical Focus

• Hematopathology
• Anatomic Pathology
• Pathology and Laboratory Medicine

Academic Appointments

• Professor - University Medical Line, Pathology
• Member, Maternal & Child Health Research Institute (MCHRI)
• Member, Stanford Cancer Institute

Administrative Appointments

• Co-Director, Immunodiagnosis Laboratory, Stanford (2005 - Present)
• Director of Faculty Development and Diversity, Stanford (2009 - 2018)
• Director of Hematopathology, Stanford (2009 - 2020)

Honors & Awards

• Undergraduate Research Award, Charles A. Dana Foundation (1986)
• Medical Scientist Training Program, Mount Sinai School of Medicine, New York (1987-1995)
• Weill Memorial Fellow in Cancer Research, Mount Sinai School of Medicine, New York (1993)
• Shalit Fellow at John Radcliffe Hospital, Oxford, UK, Leukemia Research Fund, UK (2006)
• International Cancer Technology Transfer Award, International Cancer Control, Switzerland (2010)
• Faculty Teaching Award, Department of Pathology, Stanford (2016)
• Faculty Teaching Award, Department of Pathology, Stanford (2017)
• Ronald F. Dorfman, MBBS, FRCPath Professor in Hematopathology, Stanford University School of Medicine (2018)
• Faculty Teaching Award, Department of Pathology, Stanford (2019) Faculty Teaching Award, Department of Pathology, Stanford (2021)

Boards, Advisory Committees, Professional Organizations

• Section Editor, Laboratory Investigation (2007 - 2009)
• Editorial Board, International Journal of Clinical and Experimental Pathology (2007 - 2016)
• Editorial Board, Applied Immunohistochemistry and Molecular Morphology (2008 - 2016)
• Editorial Board, Human Pathology (2008 - Present)
• Lymphoma Working Group, Eastern Coorperative Oncology Group (2010 - Present)
• Chair, Education Committee, Society for Hematopathology (2011 - 2013)
• Editorial Board, American Journal of Surgical pathology (2011 - Present)
• Member, Lunenberg Lymphoma Biomarker Consortium (2012 - Present)
• Chair, Workshop on Immunodeficiency and Dysregulation, Society for Hematopathology (2015 - 2015)
• Executive Committee, Society for Hematopathology (2017 - 2021)
• Advisory Council, International Medical Health Organization (2017 - Present)
• International Affairs Committee, Society for Hematopathology (2020 - Present)

Profesional Education

• Residency: Stanford University School of Medicine (2000) CA
• AB, Bryn Mawr College, Biology (1987)
• PhD, Mount Sinai School of Medicine, Molecular Biology (1993)
• MD, Mount Sinai School of Medicine, Medical School (1995)
• Internship: Stanford University School of Medicine (1996) CA
• Board Certification: American Board of Pathology, Anatomic Pathology (1998)